This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Bringing you the latest updates on pharma competition law, patent litigation, regulatory frameworks, compliance and licensing agreements.

Understand HCP Perspectives on Virtual/Hybrid/Live — Experiences and Preferences

Share this article

 

At the Speaker Programs Benchmarking Summit, Steven Klein, Senior Manager, HCP Engagement Management & Operationsn at Novo Nordisk, led a discussion on what HCPs expected deliverables were for attending (and/or speaking at) speaker programs prior to the pandemic. The panel went on to discuss their perspectives on how virtual/hybrid speaker programs met these expectations as well as where they may fall short, touching on how HCPs prefer to garner information and participate in speaker programs moving forward. Watch the full on-demand session in the video above.

The panelists included:

  • Shawn Tsuda, MD, FACS | Minimally Invasive General & Bariatric Surgeon, VIP SURG, PLLC
  • Doron Schneider, MD, MBA, FACP | Vice President, Population Health Services, Tandigm Health
  • Catherine Janise Mcneal, MD | Cardiologist, Baylor Scott & White Health
  • Joshua Stolker, MD | Cardiologist, Mercy Medical Group and St. Louis

Share this article

Upcoming event

European Pharma Law Academy

17 - 21 Jan 2022, Cambridge University
European Pharma Law Academy
Go to site